ChondroFiller Liquid is an innovative and minimally invasive treatment designed to repair small areas of cartilage damage in joints. While it offers many patients a promising solution, it’s important to recognize that ChondroFiller isn’t right for everyone. In this article, we’ll explore which patients may not be ideal candidates for this treatment—and why careful patient selection is essential. At the London Cartilage Clinic , under the guidance of Professor Paul Lee, patients receive comprehensive assessments in a professional and supportive environment to ensure the best possible outcomes.

Contraindications: Medical Conditions That Can Affect Treatment

Certain medical conditions make ChondroFiller an unsuitable option. These include advanced osteoarthritis , where cartilage damage is widespread throughout the joint, rather than limited to one area. Other conditions that rule out ChondroFiller include inflammatory joint diseases (such as rheumatoid arthritis), ongoing infections, tumors near the joint, gout, metabolic or autoimmune disorders, Lyme disease, and pregnancy.

These conditions can interfere with cartilage healing or increase the risks of complications. For example, inflammation from autoimmune diseases can disrupt the body’s ability to repair cartilage , while infections and tumors pose additional health risks. Pregnancy is also a contraindication due to concerns about the safety of surgical interventions. By identifying these factors before treatment, clinicians help prevent unnecessary procedures and reduce the risk of unsuccessful outcomes.

Patient Considerations: Age, Body Weight, and Commitment

In addition to underlying medical conditions, other personal factors can influence the success of ChondroFiller . Age matters: very young patients and those over 70 years old often heal more slowly, and their joint mechanics may complicate recovery. A high body mass index (BMI) also puts added stress on the joints , potentially limiting the effectiveness of the procedure.

ChondroFiller works best for small, well-defined areas of damage. Patients with larger defects—generally over 12 cm², which is about the size of a two-pence coin—may require alternative treatments. Commitment to post-treatment care is just as important; patients who have difficulty following rehabilitation plans or who are dealing with addiction may not experience the best outcomes. A thorough clinical assessment is critical to evaluate all these factors and set the stage for treatment success.

Clinical Assessment and Imaging: The Keys to Suitability

A detailed clinical evaluation is crucial in determining if ChondroFiller is appropriate. One key consideration is the presence of healthy surrounding cartilage and whether the damaged area has a stable edge, or “marginal shoulder,” to help the repair material adhere effectively. Additionally, patients with “kissing lesions”—areas where both sides of the joint are damaged—are typically not suitable for this treatment, as these scenarios put extra stress on the repair site and may impede healing.

To assess suitability, doctors rely on advanced imaging techniques like MRI scans and sometimes arthroscopy (a minimally invasive camera examination). These tests help determine the size of the cartilage defect and assess overall cartilage health . Scoring systems such as the International Knee Documentation Committee (IKDC) score may also be used to gauge joint function before and after treatment. This thorough evaluation process ensures that ChondroFiller is recommended only for patients with the best chance of success.

Expert Care at the London Cartilage Clinic

The London Cartilage Clinic places high value on expert, patient-centered care within a welcoming environment. With Professor Paul Lee ’s extensive experience in orthopaedics and rehabilitation, every patient receives a detailed assessment, including clinical examination, imaging, and consideration of lifestyle factors.

The clinic’s multidisciplinary team evaluates all relevant information before recommending ChondroFiller , ensuring only those who truly meet the treatment criteria proceed. While the clinic does not claim to have invented ChondroFiller or offer guaranteed results, their individualised approach and experience empower patients to make informed decisions about their care.

Alternative Treatments for Those Unsuitable for ChondroFiller

For patients who are not suitable for ChondroFiller , there are several alternative treatments available. Microfracture is a common option for small cartilage defects. It involves creating tiny holes in the bone beneath the damaged cartilage to stimulate new tissue growth, though this newly formed fibrocartilage is generally less durable than natural cartilage .

Autologous matrix-induced chondrogenesis (AMIC) combines microfracture with a special collagen membrane to guide tissue repair and is typically effective for defects up to about 4 cm². For larger defects (between 3 and 14 cm²), autologous chondrocyte implantation (ACI) may be considered. With ACI, a patient’s own cartilage cells are harvested, cultivated in a lab, and then reimplanted into the damaged area. While ACI often requires two surgical procedures and a longer recovery, it can result in cartilage tissue that closely resembles healthy, natural cartilage.

Each treatment has its strengths and limitations, and the best choice depends on the size of the defect, overall health, and patient preferences. Scientific reviews suggest that cell-based therapies can provide better medium-term results than microfracture, particularly for larger defects.

Conclusion and Disclaimer

In summary, ChondroFiller is not suitable for every patient. Those with advanced arthritis, certain medical conditions, large or extensive cartilage defects, extreme ages, or difficulty adhering to rehabilitation plans may benefit more from alternative treatments. Careful clinical assessment—including imaging and specialist evaluation—is essential in identifying the best candidates for ChondroFiller . At the London Cartilage Clinic , Professor Paul Lee and his team deliver expert guidance and personalised care to help each patient find the most appropriate solution for their joint health.

For personalised medical advice, please consult a qualified healthcare professional.

References

De Lucas Villarrubi, J. C., Méndez Alonso, M. Á., Sanz Pérez, M. I., Trell Lesmes, F., & Panadero Tapia, A. (2021). Acellular Matrix-Induced Chondrogenesis Technique Improves the Results of Chondral Lesions Associated With Femoroacetabular Impingement. Arthroscopy. https://doi.org/10.1016/j.arthro.2021.08.022
Perez-Carro, L., Mendoza Alejo, P. R., Gutierrez Castanedo, G., Menendez Solana, G., Fernandez Divar, J. A., Galindo Rubin, P., & Fernandez, A. A. (2021). Hip Chondral Defects: Arthroscopic Treatment With the Needle and Curette Technique and ChondroFiller. Arthroscopy Techniques, 10(7), e1729–e1735. https://doi.org/10.1016/j.eats.2021.03.011
Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller® Liquid for trapeziometacarpal osteoarthritis.